MedTrace Logo

A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer

NCT01614002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 371

Last updated 2015-06-04

No results posted yet for this study

Summary

The main purpose of this observational study with Docetaxel is to determine the number of treatment cycles and the quantity of Doce onkovis needed therefore under the special circumstance of ambulant chemotherapy.

onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective.

Secondary objectives are the evaluation of the safety and tolerability of Doce onkovis. To this purpose data regarding co medications and adverse events are also collected.

Conditions

  • Carcinoma

Sponsors & Collaborators

  • AKP Freiburg GmbH

    collaborator INDUSTRY

  • Onkovis GmbH

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01614002 on ClinicalTrials.gov